BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Z, Zhang N. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol. 2014;12:397. [PMID: 25543664 DOI: 10.1186/1477-7819-12-397] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Hani U, Osmani RAM, Yasmin S, Gowda BHJ, Ather H, Ansari MY, Siddiqua A, Ghazwani M, Fatease AA, Alamri AH, Rahamathulla M, Begum MY, Wahab S. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy. Pharmaceutics 2022;14:1576. [DOI: 10.3390/pharmaceutics14081576] [Reference Citation Analysis]
2 Lu J, Wu D, Chen S, Huang J, Xu B, Xue Z, Zheng H, Lin G, Shen L, Lin J, Zheng C, Li P, Wang J, Lin J, Chen Q, Cao L, Xie J, Peng J, Huang C. A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.01.018] [Reference Citation Analysis]
3 Li C, Yang S, Li R, Gong S, Huang M, Sun Y, Xiong G, Wu D, Ji M, Chen Y, Gao C, Yu Y. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer. ACS Appl Mater Interfaces 2022;14:7646-58. [PMID: 35104098 DOI: 10.1021/acsami.1c22720] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen L, Ge C, Feng X, Fu H, Wang S, Zhu J, Linghu E, Zheng X, Mei J. Identification of Combinations of Plasma lncRNAs and mRNAs as Potential Biomarkers for Precursor Lesions and Early Gastric Cancer. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/1458320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tong Y, Zhu Y, Zhao Y, Jiang C, Wang W, Shan Z, Sun F, Liu D, Zhang J. CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy. J Cancer 2021;12:6465-72. [PMID: 34659537 DOI: 10.7150/jca.60694] [Reference Citation Analysis]
6 Xu Y, Zhang P, Zhang K, Huang C. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188634. [PMID: 34656687 DOI: 10.1016/j.bbcan.2021.188634] [Reference Citation Analysis]
7 Pang H, Zhang W, Liang X, Zhang Z, Chen X, Zhao L, Liu K, Galiullin D, Yang K, Chen X, Hu J. Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort Study. Adv Ther 2021;38:4917-34. [PMID: 34379305 DOI: 10.1007/s12325-021-01870-z] [Reference Citation Analysis]
8 Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Miao R, Xue K, Li Z, Li Z, Ji J. Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment. BMC Gastroenterol 2021;21:283. [PMID: 34246249 DOI: 10.1186/s12876-021-01785-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Xu W, Ma Q, Wang L, He C, Lu S, Ni Z, Hua Z, Zhu Z, Yang Z, Zheng Y, Feng R, Yan C, Li C, Yao X, Chen M, Liu W, Yan M, Zhu Z. Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy. Front Oncol 2021;11:607640. [PMID: 33937020 DOI: 10.3389/fonc.2021.607640] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Tong Y, Zhao Y, Shan Z, Zhang J. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. BMC Cancer 2021;21:4. [PMID: 33402124 DOI: 10.1186/s12885-020-07666-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ma F, Zhang Y, Peng L, Zhang Z, Yang W, Chai J, Zhang B, Ji S, Hua Y, Chen X, Luo S. Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection? Ann Transl Med 2020;8:948. [PMID: 32953748 DOI: 10.21037/atm-20-3986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21. [PMID: 32512697 DOI: 10.3390/ijms21114012] [Cited by in Crossref: 219] [Cited by in F6Publishing: 167] [Article Influence: 109.5] [Reference Citation Analysis]
13 Chen Y, Xiao J, Chen X, Wang H, Liu D, Xiang J, Peng J. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. WJG 2020;26:2426-38. [DOI: 10.3748/wjg.v26.i19.2426] [Reference Citation Analysis]
14 Chen YH, Xiao J, Chen XJ, Wang HS, Liu D, Xiang J, Peng JS. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastroenterol 2020; 26(19): 2427-2439 [PMID: 32476803 DOI: 10.3748/wjg.v26.i19.2427] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Gao X, Ma T, Cui J, Zhang Y, Wang L, Li H, Ye Z. A radiomics-based model for prediction of lymph node metastasis in gastric cancer. Eur J Radiol 2020;129:109069. [PMID: 32464581 DOI: 10.1016/j.ejrad.2020.109069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Wang K, Yang J, Xu H, Cao B, Qin Q, Liao X, Wo Y, Jin Q, Cui D. Smartphone-imaged multilayered paper-based analytical device for colorimetric analysis of carcinoembryonic antigen. Anal Bioanal Chem 2020;412:2517-28. [PMID: 32067065 DOI: 10.1007/s00216-020-02475-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
17 Zhang C, Hong L, Zhang T, Sun P, Sun J, Zhou J, Wang L, Fan R, Wang Z, Cheng S, Zhong J. Clinical characteristics of small bowel tumors diagnosed by double-balloon endoscopy: Experience from a Chinese tertiary hospital. Turk J Gastroenterol 2020;31:30-5. [PMID: 32009611 DOI: 10.5152/tjg.2020.19115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Sun Z, Jia J, Du F, Yang Y, Liu C, Xiao Y, Yu J, Zhang X. Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy. Transl Cancer Res 2019;8:2680-90. [PMID: 35117026 DOI: 10.21037/tcr.2019.10.27] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Gao YS, Wang YM, Huang JJ, Zhang YF, Chen P, Yan XZ, Sun JG, Fan XJ, Han J, Chen ZL. Expression of serum tumor markers in gastric cancer with different degrees of differentiation: Significance for monitoring tumor recurrence. Shijie Huaren Xiaohua Zazhi 2019; 27(6): 361-366 [DOI: 10.11569/wcjd.v27.i6.361] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Wang SL, Yu GY, Yao J, Li ZS, Mao AR, Bai Y. Diagnostic role of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: A prospective study. J Dig Dis 2018;19:685-92. [PMID: 30345716 DOI: 10.1111/1751-2980.12681] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Abbas M, Ahmed A, Khan GJ, Baig MMFA, Naveed M, Mikrani R, Cao T, Naeem S, Shi M, Dingding C. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Curr Probl Cancer 2019;43:5-17. [PMID: 30172422 DOI: 10.1016/j.currproblcancer.2018.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
22 Liu X, Wu Z, Lin E, Li W, Chen Y, Sun X, Zhou Z. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy. Clin Nutr. 2019;38:1853-1860. [PMID: 30075998 DOI: 10.1016/j.clnu.2018.07.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
23 Zhou H, Dong A, Xia H, He G, Cui J. Associations between CA19-9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer. Oncol Lett 2018;16:1079-86. [PMID: 29963185 DOI: 10.3892/ol.2018.8731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kotzev AI, Draganov PV. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? Gastrointest Tumors. 2018;5:1-13. [PMID: 30574476 DOI: 10.1159/000488240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
25 Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H. Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study. Onco Targets Ther 2018;11:1353-62. [PMID: 29559793 DOI: 10.2147/OTT.S152471] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells. Oncotarget 2017;8:2293-306. [PMID: 27906682 DOI: 10.18632/oncotarget.13725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
27 Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Sci Rep. 2018;8:2732. [PMID: 29426902 DOI: 10.1038/s41598-018-21048-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 91] [Article Influence: 13.3] [Reference Citation Analysis]
28 Wang W, Chen XL, Zhao SY, Xu YH, Zhang WH, Liu K, Chen XZ, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Oncotarget. 2016;7:35423-35436. [PMID: 27097114 DOI: 10.18632/oncotarget.8770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
29 Liu X, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection. Oncotarget. 2016;7:35446-35453. [PMID: 27147574 DOI: 10.18632/oncotarget.9060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
30 Guo J, Chen S, Li S, Sun X, Li W, Zhou Z, Chen Y, Xu D. A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4). Oncotarget 2018;9:4814-22. [PMID: 29435143 DOI: 10.18632/oncotarget.23307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Shafaghi A, Mansour- Ghanaei F, Joukar F, Nabavi F, Mansour- Ghanaei A, Esrafilian Soltani A. Stage Association of Preoperative Serum Carcinoembryonic Antigen with Gastric Adenocarcinoma in Iranian Patients. Asian Pac J Cancer Prev. 2017;18:2669-2672. [PMID: 29072067 DOI: 10.22034/apjcp.2017.18.10.2669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Namikawa T, Kawanishi Y, Fujisawa K, Munekage E, Iwabu J, Munekage M, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer. Surg Today. 2018;48:388-394. [PMID: 29043453 DOI: 10.1007/s00595-017-1598-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
33 Ke D, Li H, Zhang Y, An Y, Fu H, Fang X, Zheng X. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget 2017;8:21516-25. [PMID: 28423525 DOI: 10.18632/oncotarget.15628] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
34 Wang K, Diao F, Ye Z, Zhang X, Zhai E, Ren H, Li T, Wu H, He Y, Cai S, Chen J. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer 2017;36:75. [PMID: 28899420 DOI: 10.1186/s40880-017-0243-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 70] [Article Influence: 10.2] [Reference Citation Analysis]
35 Yin ZH, Jiang XW, Shi WB, Gui QL, Yu DF. Expression and Clinical Significance of ILF2 in Gastric Cancer. Dis Markers 2017;2017:4387081. [PMID: 28831206 DOI: 10.1155/2017/4387081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
36 Ding D, Song Y, Yao Y, Zhang S. Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer. Oncol Lett 2017;14:2982-90. [PMID: 28928836 DOI: 10.3892/ol.2017.6547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
37 Sánchez de Molina ML, Díaz Del Arco C, Vorwald P, García-Olmo D, Estrada L, Fernández-Aceñero MJ. Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma. Clin Transl Oncol 2018;20:253-7. [PMID: 28653276 DOI: 10.1007/s12094-017-1707-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Sun Z, Wang F, Zhou Q, Yang S, Sun X, Wang G, Li Z, Zhang Z, Song J, Liu J, Yuan W. Pre-operative to post-operative serum carcinoembryonic antigen ratio is a prognostic indicator in colorectal cancer. Oncotarget 2017;8:54672-82. [PMID: 28903373 DOI: 10.18632/oncotarget.17931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
39 Zheng X, Fan L, Zhou P, Ma H, Huang S, Yu D, Zhao L, Yang S, Liu J, Huang A, Cai C, Dai X, Zhang T. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. Transl Oncol. 2017;10:431-441. [PMID: 28448959 DOI: 10.1016/j.tranon.2017.02.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
40 Liu S, Feng F, Xu G, Liu Z, Tian Y, Guo M, Lian X, Cai L, Fan D, Zhang H. Clinicopathological features and prognosis of gastric cancer in young patients. BMC Cancer. 2016;16:478. [PMID: 27418046 DOI: 10.1186/s12885-016-2489-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
41 Dang Y, Ouyang X, Wang K, Zhang F, Huang Q. Evaluation of the Clinical Significance of Serum Carcinoembryonic Antigen in Patients with Resectable Gastric Adenocarcinoma. Arch Med Res 2016;47:196-9. [PMID: 27387021 DOI: 10.1016/j.arcmed.2016.06.007] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Chen SL, Li JP, Li LF, Zeng T, He X. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma. Int J Mol Sci 2016;17:E911. [PMID: 27294917 DOI: 10.3390/ijms17060911] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
43 Laocharoensuk R. Development of Electrochemical Immunosensors towards Point-of-care Cancer Diagnostics: Clinically Relevant Studies. Electroanalysis 2016;28:1716-29. [DOI: 10.1002/elan.201600248] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
44 Yan X, Wang K, Lu W, Qin W, Cui D, He J. CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4. Nanoscale Res Lett 2016;11:138. [PMID: 26969591 DOI: 10.1186/s11671-016-1355-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
45 Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy. Drug Des Devel Ther 2016;10:241-58. [PMID: 26966350 DOI: 10.2147/DDDT.S88743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
46 Liu CC, Yang H, Zhang R, Zhao JJ, Hao DJ. Tumour-associated antigens and their anti-cancer applications. Eur J Cancer Care (Engl). 2017;26. [PMID: 26853428 DOI: 10.1111/ecc.12446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
47 Guo H, Zhou X, Lu Y, Xie L, Chen Q, Keller ET, Liu Q, Zhou Q, Zhang J. Translational progress on tumor biomarkers. Thorac Cancer 2015;6:665-71. [PMID: 26557902 DOI: 10.1111/1759-7714.12294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
48 Zhou X, Yin C, Dang Y, Ye F, Zhang G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep. 2015;5:11516. [PMID: 26096073 DOI: 10.1038/srep11516] [Cited by in Crossref: 189] [Cited by in F6Publishing: 212] [Article Influence: 27.0] [Reference Citation Analysis]
49 Fernandes E, Ferreira JA, Andreia P, Luís L, Barroso S, Sarmento B, Santos LL. New trends in guided nanotherapies for digestive cancers: A systematic review. J Control Release 2015;209:288-307. [PMID: 25957905 DOI: 10.1016/j.jconrel.2015.05.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
50 Căinap C, Nagy V, Gherman A, Cetean S, Laszlo I, Constantin AM, Căinap S. Classic tumor markers in gastric cancer. Current standards and limitations. Clujul Med 2015;88:111-5. [PMID: 26528057 DOI: 10.15386/cjmed-409] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]